NICE/FDA12 Mar 2023 10:35
The board will have sense not to announce a raise before NICE/FDA news. The share price will reach around 50p+ towards the end of March on the anticipation of nice recommendation/FDA news.
A raise will be announced straight after, perhaps on the day of or not soon after.
FDA news will have significant upside on the SP, much more so then NICE. There will definitely be more interest in the stock in the month ahead
All of course, My view.
Exciting two weeks ahead.